MedPath

Anti-pollution Effects of AP Green Tea Extracts

Not Applicable
Completed
Conditions
Respiratory Conditions Due to Unspecified External Agent
Interventions
Dietary Supplement: AP green tea extracts
Registration Number
NCT04340375
Lead Sponsor
Amorepacific Corporation
Brief Summary

The objective of this clinical trial is to evaluate the anti-pollution effects of AP green tea extracts in subjects with discomforts related to the respiratory system by prolonged exposure to particulate matter in air pollution

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Subjects aged 19 years or over
  • Subjects with discomforts related to the respiratory system by prolonged exposure to particulate matter in air pollution
  • Subjects who voluntarily decide to participate in this clinical study and sign the informed consent form on their own or through their representatives
Exclusion Criteria
  • At the screening visit, subjects who were diagnosed with acute or chronic respiratory disease and undergoing medication.
  • Subjects who were diagnosed with ventricular associated disease, unstable and uncontrolled chronic medical disease, or active malignant tumor and undergoing medication within 4 weeks prior to the first administration of the investigational product
  • Subjects who show a level of ALT/AST of 2 times or more the upper limit of normal as a result of a screening test and have acute or chronic hepatitis or known liver cirrhosis
  • In addition to the above, subjects who are determined to be ineligible to participate in the clinical study according to the investigator's medical opinion

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AP green tea extractsAP green tea extracts8 weeks
Primary Outcome Measures
NameTimeMethod
Pulmonary function test8 weeks

Improvement in pulmonary function test

Heavy metals8 weeks

Blood concentration of heavy metals

Respiratory health survey8 weeks

Patients' self evaluation of COPD Assessment Test

Biomarkers8 weeks

Blood concentration of biomarkers (Inflammatory cytokines)

Secondary Outcome Measures
NameTimeMethod
Bronchial assessment8 weeks

Patients' self evaluation of Bronchiectasis Health Questionnaire

Trial Locations

Locations (1)

Hanyang University Seoul Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath